Trial Profile
A retrospective study to evaluate the safety and efficacy of sofosbuvir and simeprevir in patients with genotype 1 chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2015 New trial record